MyFinsight
Home
Blog
About
Proceeds from stock
option exercises
$2,857K
(1663.58%↑ Y/Y)
Proceeds from issuance of
common stock pursuant...
$106K
(29.27%↑ Y/Y)
Net cash provided by
financing activities
$2,963K
(1114.34%↑ Y/Y)
Net decrease in
cash, cash...
-$43,627K
(31.74%↑ Y/Y)
Canceled cashflow
$2,963K
Stock-based compensation
$11,608K
(-63.19%↓ Y/Y)
Depreciation
$4,112K
(-55.29%↓ Y/Y)
Accrued and other
current liabilities
$3,508K
(-3.52%↓ Y/Y)
Amortization of operating
lease right-of-use...
$2,076K
(-48.98%↓ Y/Y)
Accounts payable
$982K
(-13.02%↓ Y/Y)
Prepaid expenses and
other current assets
-$340K
(-214.81%↓ Y/Y)
Other assets
-$15K
(77.94%↑ Y/Y)
Net cash used in
operating activities
-$46,238K
(27.47%↑ Y/Y)
Canceled cashflow
$22,641K
Net cash used in
investing activities
-$352K
(12.66%↑ Y/Y)
Net loss
-$65,643K
(41.27%↑ Y/Y)
Operating lease liability
-$3,236K
(36.96%↑ Y/Y)
Purchase of property and
equipment
$352K
(-12.66%↓ Y/Y)
Back
Back
Cash Flow
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)
source: myfinsight.com